Reyes Bernabé

机构：Hospital Universitario Virgen del Rocío

发表论文 18 篇 · 总被引 692 次 · h-index 8

代表论文

• Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer (2023 · New England Journal of Medicine · 被引 473)
• Nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage IIIA NSCLC: Primary endpoint results of pathological complete response (pCR) from phase II NADIM II trial. (2022 · Journal of Clinical Oncology · 被引 64)
• Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A (2025 · Journal of Thoracic Oncology · 被引 32)
• Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non–Small-Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 31)
• KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC. (2024 · Journal of Clinical Oncology · 被引 26)
• Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics (2022 · BMC Cancer · 被引 17)